1600528-97-9

Basic information

• Product Name: p-tolyl 3-O-allyl-2,4-di-O-(2-napthyl)methyl-1-thio-β-D-glucopyranoside
• Synonyms: p-tolyl 3-O-allyl-2,4-di-O-(2-napthyl)methyl-1-thio-β-D-glucopyranoside
• CAS NO: 1600528-97-9
• Molecular Weight: 606.783
• Mol File: 1600528-97-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: p-tolyl 3-O-allyl-2,4-di-O-(2-napthyl)methyl-1-thio-β-D-glucopyranoside(CAS DataBase Reference)
• NIST Chemistry Reference: p-tolyl 3-O-allyl-2,4-di-O-(2-napthyl)methyl-1-thio-β-D-glucopyranoside(1600528-97-9)
• EPA Substance Registry System: p-tolyl 3-O-allyl-2,4-di-O-(2-napthyl)methyl-1-thio-β-D-glucopyranoside(1600528-97-9)

Safety Data

• Hazardous Substances Data: 1600528-97-9(Hazardous Substances Data)

Upstream product

• 1600528-95-7 C₁₆H₂₂O₅S 
• 77196-31-7 2-(dimethoxymethyl)naphthalene 

Downstream Products

• 1600528-86-6 2-[3,4-bis(tert-butyldimethylsilyloxy)phenyl]ethyl-6-O-[(E)-3,4-bis-(O-tert-butyldimethylsilyl)caffeoyl]-3-O-allyl-2,4-di-O-(2-naphthyl)methyl-β-D-glucopyranose 
• 106972-94-5 calceolarioside B 
• 1600528-84-4 p-tolyl 6-O-[(E)-3,4-bis-(O-tert-butyldimethylsilyl)-caffeoyl]-3-O-allyl-2,4-di-O-(2-naphthyl)methyl-1-thio-β-D-glucopyranoside 

Relevant articles and documents

A general synthetic strategy and the anti-proliferation properties on prostate cancer cell lines for natural phenylethanoid glycosides

A general strategy for the synthesis of phenylethanoid glycosides (PhG) including echinacoside 1, acteoside 2, calceolarioside-A 3 and calceolarioside-B 4 is reported. The strategy features the application of low substrate concentration glycosylation and N-formyl morpholine modulated glycosylation methods for the construction of 1,2-trans β- and α-glycosidic bonds. The reported strategy does not invoke the use of the participatory acyl protecting function, which is incompatible with the ester function present in target PhG compounds. A preliminary study of the anti-proliferation properties of the PhG compounds 1-4 was performed; the acteoside 2 exhibited the best inhibition on the prostatic cancer cell proliferation. This journal is the Partner Organisations 2014.